Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Annual Report · 10-K

CONMED Corporation

CNMDNYSEEQUITYCurrent

Annual Report

Filed Feb 18, 2025Accepted Feb 18, 2025, 10:15 AM ESTCIK 816956Accession 0000816956-25-000004
Share

Company context

CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, and thoracic surgery. For more information, visit www.conmed.com.

Current securities

Recent company filings

  1. 10-Q filingJul 29, 2026
  2. Results of Operations and Financial ConditionJul 29, 2026
  3. 4 filingJul 2, 2026
  4. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureJun 17, 2026
  5. 11-K filingJun 16, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗